pegflilgrastim-fpgk

CHEBI:CHEBI_756743

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2613769
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20251231
dosage_form
INJECTION, SOLUTION
route
SUBCUTANEOUS
marketing_category
BLA
labeler_name
Fresenius Kabi USA, LLC
manufacturer_name
Fresenius Kabi USA, LLC
nui
N0000175666
pharm_class_epc
Leukocyte Growth Factor [EPC]
pharm_class
Granulocyte-Macrophage Colony-Stimulating Factor [CS]
pharm_class_pe
Increased Myeloid Cell Production [PE]
pharm_class_cs
Granulocyte Colony-Stimulating Factor [CS]
marketing_start_date
20221006
package_marketing_start_date
20221006
active_ingredient_name
PEGFILGRASTIM
active_ingredient_strength
6 mg/.6mL
unii
3A58010674
generic_name
pegflilgrastim-fpgk
brand_name
STIMUFEND
brand_name_base
STIMUFEND
product_ndc
65219-371
application_number
BLA761173
spl_id
90fa8a88-1bd6-49cf-a482-ccbc0d315b3d
package_ndc
65219-371-10
package_description
1 BLISTER PACK in 1 CARTON (65219-371-10) / 1 SYRINGE in 1 BLISTER PACK / .6 mL in 1 SYRINGE
spl_set_id
b44bcb82-7e60-4dab-a658-115bdf5c053c
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class